These collaborations have been a mainstay of Alkermes’ scientific and commercial success, leading to numerous first-in-class products including RISPERDAL® CONSTA®, INVEGA® SUSTENNA®, AMPYRA® and BYDUREON®.
Developing new partnerships remains a key strategy for Alkermes. We bring scientific excellence, deep product development expertise and a unique capacity to identify and address opportunities across a variety of drug technologies and disease states.
To explore business opportunities with Alkermes, please contact us at email@example.com.
Non-confidential proposals may be mailed directly to our Business Development group:
Partial List of Alkermes Partners: